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Abstract
Objectives To compare aortic size and stiffness parameters on MRI between bicuspid aortic valve (BAV) and tricuspid aortic
valve (TAV) patients with aortic stenosis (AS).
Methods MRI was performed in 174 patients with asymptomatic moderate-severe AS (mean AVAI 0.57 ± 0.14 cm2/m2) and 23
controls on 3T scanners. Valve morphology was available/analysable in 169 patients: 63 BAV (41 type-I, 22 type-II) and 106
TAV. Aortic cross-sectional areas were measured at the level of the pulmonary artery bifurcation. The ascending and descending
aorta (AA, DA) distensibility, and pulse wave velocity (PWV) around the aortic arch were calculated.
Results The AA and DA areas were lower in the controls, with no difference in DA distensibility or PWV, but slightly lower AA
distensibility than in the patient group. With increasing age, there was a decrease in distensibility and an increase in PWV. After
correcting for age, the AA maximum cross-sectional area was higher in bicuspid vs. tricuspid patients (12.97 [11.10, 15.59] vs.
10.06 [8.57, 12.04] cm2, p < 0.001), but there were no significant differences in AA distensibility (p = 0.099), DA distensibility
(p = 0.498) or PWV (p = 0.235). Patients with BAV type-II valves demonstrated a significantly higher AA distensibility and
lower PWV compared to type-I, despite a trend towards higher AA area.
Conclusions In patients with significant AS, BAV patients do not have increased aortic stiffness compared to those with TAV
despite increased ascending aortic dimensions. Those with type-II BAV have less aortic stiffness despite greater dimensions. These
results demonstrate a dissociation between aortic dilatation and stiffness and suggest that altered flow patterns may play a role.
Key Points
• Both cellular abnormalities secondary to genetic differences and abnormal flow patterns have been implicated in the patho-
physiology of aortic dilatation and increased vascular complications associated with bicuspid aortic valves (BAV).
• We demonstrate an increased ascending aortic size in patients with BAV and moderate to severe AS compared to TAV and
controls, but no difference in aortic stiffness parameters, therefore suggesting a dissociation between dilatation and stiffness.
• Sub-group analysis showed greater aortic size but lower stiffness parameters in those with BAV type-II AS compared to BAV
type-I.
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AA Ascending aorta
AS Aortic stenosis
BAV Bicuspid aortic valve
DA Descending aorta
LGE Late gadolinium enhancement
LV Left ventricular
MRI Magnetic resonance imaging
PP Pulse pressure
PWV Pulse wave velocity
TAV Tricuspid aortic valve
Introduction
Bicuspid aortic valve (BAV) is the most common congenital
cardiac anomaly, affecting 1–2% of the general population [1].
It is associated with an increased incidence of aortic root dila-
tation [2] and vascular complications, with the reported
pooled risk of aortic dissection being as high as 4%[3, 4].
Cellular abnormalities, such as cystic medial necrosis and ap-
optosis, have been observed in the aortic walls of patients with
BAV disease [5, 6]. Two dominant hypotheses have been pro-
posed to explain these abnormalities: (i) the changes are due to
a primary aortopathy which is genetically mediated [5, 6] and
(ii) abnormal flow patterns associated with BAV disease lead
to secondary changes in the aorta [7, 8].
The viscoelastic properties of the aorta are essential to
maintain proximal and distal arterial flow and organ per-
fusion, and arterial stiffness has been shown to be inde-
pendently associated with the development of cardiovas-
cular disease [9]. Pulse wave velocity (PWV), which is
the rate of propagation of the systolic wave front down a
vessel, is a marker of vessel wall stiffness and inversely
related to its distensibility. It can most accurately be mea-
sured invasively by intra-arterial pressure measurements;
however, its non-invasive assessment is more practical.
Magnetic resonance imaging (MRI) allows direct (aortic
distensibility) and indirect (PWV) measurement of arterial
stiffness in a single examination, at multiple sites, with
good agreement compared to invasive measurements and
with excellent reproducibility [10]. Abnormalities of aor-
tic stiffness have been found in patients with normally
functioning BAVs. Lower aortic distensibility and higher
aortic stiffness index on echocardiography or PWV on
MRI have been demonstrated in patients with BAV com-
pared to controls [11–14]. The interpretation of these find-
ings was that there is an intrinsic aortopathy associated
with BAV.
However, no studies to date have reported on whether
there are significant differences in aortic stiffness param-
eters in patients with aortic stenosis (AS) secondary to
BAV disease and degenerative AS of a tricuspid valve
(TAV). If patients with BAV did have a genetic predispo-
sition to the development of aortopathy, one would expect
stiffness parameters to be increased in comparison to
those with TAV. We hypothesised that patients with AS
and BAV would have significantly greater thoracic aortic
stiffness measured by MRI than patients with tricuspid AS
and healthy controls without valve disease.
Materials and methods
Study population
Asymptomatic patients with moderate to severe AS were pro-
spectively recruited as part of a multicentre study conducted in
the UK (PRIMID-AS study) [15]. Patients with more than
mild degree of other valve disease, including aortic regurgita-
tion, were excluded. Asymptomatic controls with no valve
disease were also recruited for comparison.
Ethics, consent, and permissions
The study was approved by the United Kingdom National
Research Ethics Service (11/EM/0410) and written informed
consent was obtained from all subjects before participation.
Echocardiography
All subjects underwent a comprehensive trans-thoracic
echocardiogram as per international guidelines, to quan-
tify AS severity. In addition, mitral inflow velocities
and tissue Doppler imaging (TDI) was used to assess
diastolic function. Pulsed-wave Doppler was performed
at the mitral valve tips to calculate the E/A ratio, and
pulsed-wave TDI was used to measure the septal and
lateral mitral annular velocity, for calculation of the sep-
tal and lateral E/e’.
MRI image acquisition
Cine imaging was performed as previously described
[16] on 3T scanners to determine left ventricular (LV)
volumes, mass and function. In addition, steady-state
free precession (SSFP) cine images of the aortic valve
(or gradient-echo if significant artefacts were present),
and a high temporal resolution cine image of the
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ascending (AA) and descending aorta (DA) at the level
of the pulmonary artery bifurcation (slice thickness
6 mm, reconstructed to 40 phases, temporal resolution
~ 20 ms, matrix 192 × 256), were acquired. These cine
images were used to measure aortic cross-sectional areas
throughout the cardiac cycle and calculate distensibility
[17] (Fig. 1). A retrospectively gated phase-contrast ve-
locity-encoded sequence (typical parameters: slice thick-
ness 5 mm, VENC 250 cm/s, reconstructed to 100–128
phases, temporal resolution ~ 10 ms, TE 4 ms, matrix
176 × 256), optimised for the study with high temporal
resolution and a large number of reconstructed phases,
was acquired perpendicular to the ascending and de-
scending thoracic aorta to calculate through-plane flow.
As the planning of the slice was far away from the
aortic valve, a VENC of 250 cm/s was adequate in most
cases, but if aliasing artefact was noted, then a repeat
acquisition with a slightly higher VENC was performed.
Brachial artery blood pressure was recorded at the time
of the aortic cine acquisition to calculate the pulse pres-
sure. A sagittal oblique view of the aortic arch was
acquired to calculate the distance between sections for
flow measurements in the ascending and descending
aorta (Fig. 2). In addition late gadolinium enhancement
(LGE) and pre- and post-contrast T1 mapping was per-
formed for calculation of extracellular volume fraction,
as previously described [16, 18].
MRI image analysis
All analyses were performed offline at the core lab, blinded to
patient details, by a single observer (AS). LV volume and
function were assessed using cvi42 V5 (circle cardiovascular
imaging), excluding papillary muscle and trabeculations from
the myocardial mass [19]. Valve morphology was classified
according to Schaefer [20] with fusion of left and right coro-
nary cusps in type-I BAVand right and non-coronary cusps in
type-II BAV patients (there were no type-III patients in this
cohort). Aortic root dimensions were measured at the annulus,
sinus of Valsalva, sinotubular junction and proximal AA on
the standard 3-chamber and the coronal LVOT views and an
average was taken. Ascending and descending maximum and
minimum aortic areas were measured from the aortic cine at
the pulmonary artery bifurcation level. Aortic distensibility (in
10−3 mmHg−1) was calculated using the following equation
[14, 17]:
Distensibility ¼ Amax Aminð Þ= Amin PPð Þ½ ;
where Amax and Amin are the maximum and minimum aortic
cross-sectional areas, and PP is the pulse pressure, i.e., systolic
blood pressure − diastolic blood pressure (mmHg).
PWV was assessed in the segment including the ascending
aorta, the aortic arch and the proximal descending aorta up to
the level of the pulmonary artery bifurcation (Fig. 2). PWV (in
m/s) was calculated from:
PWV ¼ Δx=Δt;
where Δx is the distance around the aortic arch between the
two sections through the ascending and descending aorta, and
Δt is the transit time delay of two volume flow rate curves for
the descending and ascending aorta. The sagittal oblique view
of the aorta was used to measure the distance around the aortic
arch (Δx), taking the mean of the two distance measures for
the outer and inner borders of the aortic lumen. The software
package ‘Jim’ (Version 7, Xinapse Systems) was used to cal-
culate Δt from the volume flow rate curves from the AA and
DA. A maximum in the cross-correlation between these
curves was used to estimate the transit time of the pressure
wave around the arch.
Statistical analysis
Statistical tests were performed using SPSS 24.0 software
(Statistical Package for the Social Sciences). Normality was
assessed using the Shapiro-Wilk test, histograms and Q-Q
Fig. 1 End-diastolic (a) and end-
systolic (b) frames from SSFP
cine image of the ascending (top
larger region) and descending
(bottom smaller region) aorta,
used for measurement of aortic
dimensions and distensibility
calculation
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plots. For continuous data, summary statistics are expressed as
mean ± standard deviation. Log transformation was per-
formed for non-normally distributed data. An independent
sample t test was used to compare normally distributed or
log-transformed data between bicuspid and tricuspid patients,
and between patients and controls. The Mann-Whitney test
was used for non-parametric data comparison. The bicuspid
group was further split by their sub-types (type-I, and type-II)
and compared to tricuspid patients, using ANCOVA model-
ling, adjusted to take age into account. All p values < 0.05
were considered statistically significant. Univariate associa-
tions of distensibility and PWV were explored using linear
regression analysis. Variables were then selected to be entered
into a stepwise multivariable model based on statistical signif-
icance (p < 0.05) or clinical importance, whilst avoiding co-
linear variables.
Results
Comparison of AS with controls
Of 174 patients recruited, aortic valve morphology classifica-
tion was possible in 169 (due to missing or unanalysable aortic
valve cine imaging in 5 patients), with 63 BAV and 106 TAV
patients forming the final population. Distensibility was not
measurable in six of these patients due to aortic cine images
not being available, and PWV was missing in eight due to
missing flow images or artefacts. There was no difference in
age and gender distribution between the 23 controls and overall
AS group (Table 1). Patients had a higher incidence of hyper-
tension and hyperlipidaemia, although treated hypertension was
not excluded from the control group, to assess the incremental
effect of AS on LV remodelling. AS patients demonstrated
significantly higher LV volumes, mass and mass/volume and
more LGE than controls. The aortic root measurements were
higher in patients than controls at the annulus and proximal AA
levels. The AA and DA areas were higher in patients, with no
difference in DA distensibility or PWV, but slightly higher AA
distensibility (Table 2).
Comparison between bicuspid and tricuspid groups
Baseline characteristics
The BAV group was significantly younger, with a lower inci-
dence of hypertension and statin use and higher diastolic blood
pressure than those with tricuspid AS (Table 1). The TAVgroup
also had higher mean pressure gradient but similar peak gradi-
ent and aortic valve area index. Both groups had similar degree
of LV remodelling, late gadolinium enhancement and extracel-
lular volume fraction. The aortic root diameters were larger in
BAV than TAV group at all levels (Table 1).
Aortic area, distensibility and PWV
The maximum and minimum cross-sectional AA areas were
significantly higher in bicuspid patients and this remained
statistically so even after correcting for age (Table 2). There
was no difference in the age-corrected DA cross-sectional
area. With increasing age, there was a decrease in distensibil-
ity (r = -0.45, p < 0.001 for the AA; r = -0.64, p < 0.001 for
DA) and an increase in PWV (r = 0.38, p < 0.001) (Fig. 3a–
c). After correcting for age, there was no significant difference
Fig. 2 Pulse wave velocity calculation. a Sagittal oblique cine of the aorta
for measurement of Δx (average of outer and inner distance in white
dashed line). b Aortic flow sequence used for calculation of Δt, i.e., the
transit delay, which was estimated from the cross-correlation between the
flow rate curves for the ascending (red) and descending (green) aorta (see
text for details)
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in AA distensibility, DA distensibility or PWV between bicus-
pid and tricuspid patients (Table 2). In addition, AA area did
not correlate with AA distensibility (Fig. 3d).
Comparison by bicuspid type-I, and type-II sub-groups
There were no significant differences in age, gender, resting
haemodynamics, LV function or AS severity between the two
BAV sub-groups. There were significant differences in age-
corrected AA area, AA distensibility and PWV between the
three groups (tricuspid, bicuspid type-I, and type-II) (Table 3
and Fig. 4). Post-HOC analysis revealed a significantly higher
AA area in both bicuspid sub-groups compared to tricuspid
patients, and a significantly higher AA distensibility and low-
er PWV in the bicuspid type-II sub-group compared to bicus-
pid type-I patients. There were no significant differences in the
DA area or distensibility between the sub-groups.
Associations of AA distensibility and PWV
The univariate associations of AA distensibility and PWV in
the patient group, both before and after adjusting for age, are
Table 1 Demographic, echocardiographic, and MRI data for those with bicuspid and tricuspid aortic stenosis
Variable Bicuspid
(n = 63)
Tricuspid
(n = 106)
p value
(bi vs tri)
All AS
(n = 169)
Controls
(n = 23)
p value
(AS vs control)
Age (years) 64.6 [51.1, 69.7] 71.4 [65.8, 77.3] < 0.001* 69.3 [61.5, 75.6] 66.0 [61.0, 74.8] 0.935
Male (%) 73.0 77.4 0.524 75.7 69.6 0.521
BSA (m2) 1.92 ± 0.20 1.97 ± 0.20 0.166 1.95 ± 0.20 1.93 ± 0.18 0.685
Hypertension (%) 44.4 60.4 0.044* 54.4 26.1 0.011*
Hyperlipidaemia (%) 47.6 58.5 0.390 54.4 21.7 < 0.001*
Diabetes (%) 7.9 17.9 0.072 14.2 8.7 0.469
Statin (%) 49.2 67.9 0.016* 60.9 43.5 0.110
ACEI/ARB (%) 42.9 47.2 0.586 45.6 21.7 0.030*
B-blocker (%) 34.9 30.2 0.524 32.0 4.3 0.006*
HR (bpm) 72.1 ± 10.7 69.3 ± 11.6 0.119 70.3 ± 11.3 72.6 ± 8.2 0.364
SBP (mmHg) 142.7 ± 21.3 149.3 ± 20.6 0.050 146.8 ± 21.1 154.1 ± 25.0 0.132
DBP (mmHg) 80.6 ± 11.0 74.9 ± 9.9 0.001* 77.0 ± 10.6 82.0 ± 9.4 0.032*
PP (mmHg) 62.01 ± 16.4 74.41 ± 19.9 < 0.001* 69.8 ± 19.5 72.02 ± 24.0 0.621
Echocardiographic data
AV Vmax (m/s) 3.96 ± 0.56 3.79 ± 0.55 0.057 3.86 ± 0.56 1.36 ± 0.27 < 0.001*
Mean gradient (mmHg) 37.9 ± 13.1 33.7 ± 11.6 0.032* 35.3 ± 12.3 4.2 ± 1.6 < 0.001*
AVAI (cm2/m2) 0.58 ± 0.16 0.57 ± 0.13 0.773 0.57 ± 0.14 1.71 ± 0.36 < 0.001*
E/A 0.92 ± 0.32 0.85 ± 0.27 0.204 0.88 ± 0.29 0.84 ± 0.23 0.523
Septal E/e’ 12.14 ± 4.62 12.44 ± 5.02 0.734 12.33 ± 4.86 10.67 ± 3.34 0.115
Lateral E/e’ 9.24 ± 3.96 10.21 ± 3.63 0.073 9.86 ± 3.77 8.07 ± 2.97 0.031*
MRI data
LVEDVI (ml/m2) 88.3 ± 18.4 86.4 ± 18.1 0.505 87.1 ± 18.2 78.2 ± 9.4 0.001*
LVEF (%) 57.0 ± 4.1 56.7 ± 5.1 0.668 56.8 ± 4.8 58.9 ± 3.7 0.050
LVMI (g/m2) 56.5 [47.2, 66.4] 54.9 [47.7, 64.5] 0.649 55.6 [47.6, 65.6] 42.2 [39.7, 47.9] < 0.001*
LV mass/volume 0.66 ± 0.12 0.67 ± 0.11 0.631 0.66 ± 0.11 0.57 ± 0.08 < 0.001*
LGE (g) 2.67 [0.77, 4.96] 2.20 [0.83, 6.22] 0.904 2.44 [0.81, 6.08] 0.77 [0.40, 2.22] 0.001*
ECV (%) 24.48 ± 2.46 24.91 ± 2.33 0.350 24.8 ± 2.4 25.05 ± 2.57 0.590
Annulus (mm) 25.53 ± 2.69 23.76 ± 2.44 < 0.001* 24.42 ± 2.67 22.82 ± 2.23 0.006*
SoV (mm) 34.82 ± 4.00 32.92 ± 3.81 0.002* 33.63 ± 3.98 33.50 ± 3.78 0.880
STJ (mm) 29.52 ± 3.88 27.16 ± 3.67 < 0.001* 28.04 ± 3.91 27.41 ± 3.00 0.456
Proximal AA (mm) 36.40 ± 5.22 31.42 ± 4.13 < 0.001* 33.27 ± 5.15 29.75 ± 2.93 < 0.001*
Data presented as mean, with standard deviation in parentheses or median with 25th and 75th centile in parenthesis
SBP systolic blood pressure, DBP diastolic blood pressure, AVAI aortic valve area indexed to body surface area, MRI magnetic resonance imaging,
LVEDVI left ventricular end-diastolic volume index, LVMI left ventricular mass index, LVEF left ventricular ejection fraction, SoV sinus of valsalva, STJ
sinotubular junction, AA ascending aorta
*Significant difference on unpaired t test or Mann Whitney-U test, as appropriate
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summarised in supplemental Tables 1 and 2. Age was the only
independent factor associated with both parameters after en-
tering the following variables into a stepwise multivariable
model: age, sex, BMI, valve subtype, diabetes, hypertension
(or PP instead for PWV), and eGFR.
Discussion
Our results show no statistically significant differences in aor-
tic distensibility and PWV between bicuspid and tricuspid
patients with AS, despite increased AA diameters in those
with BAV. On further analysis, we found bicuspid type-II
patients to have higher AA distensibility and lower aortic
stiffness (PWV) than their type-I counterparts, despite a trend
towards the highest AA area. The strengths of this study are
the multicentre design, core lab blinded analysis, moderately
large population, classification of valve morphology, and
measurement of aortic stiffness with MRI, which allowed
localised assessment in the area of interest.
Aortic area
We have confirmed findings from previous echocardiographic
studies that patients with BAV have a greater degree of AA
dilatation compared to tricuspid controls, either with or with-
out valvular stenosis or regurgitation [21], and out of propor-
tion to the degree of valvular dysfunction [2, 22]. Several
studies have also looked at the relationship between the mor-
phology of BAVand aortic dimensions, with mixed findings.
Novaro et al found type-II BAV patients to have slightly
higher mid-ascending aortic dimensions compared to type-I,
though this did not reach statistical significance [23]. Type-II
BAVs have also been associated with a larger aortic arch and
ascending aorta [20]. However, Cecconi et al found no differ-
ence in aortic dimensions in 162 younger patients with type-1
and type-II BAV, although the average age of that cohort was
only 23.6 years and aortic dimensions did strongly correlate
with age [24].
Aortic stiffness
Distensibility and PWV are markers of arterial wall stiffness
that are inversely related according to the Bramwell and Hill
equation [25] and reflect the elastic properties of the aorta.
Aortic distensibility is principally governed by the composi-
tion of the aortic wall intra-cellular matrix and luminal mean
arterial pressure. Previous MRI studies have also shown that
distensibility decreases and PWV increases with age [17, 26,
27], which is the likely reason for the stiffness parameters in
our controls, who were older compared to the BAV group.
Echocardiographic and MRI studies have found lower disten-
sibility and higher aortic stiffness parameters in BAV patients
without significant stenosis or regurgitation, compared to con-
trols [11, 13]. In one echocardiographic study of 32 BAV
patients with AS and 32 controls, aortic stiffness index was
higher in the BAV group, but there was no significant differ-
ence in distensibility between the groups [12]. This suggests
that the presence of stenosis may result in progressively re-
duced distensibility and increased PWV in both bicuspid and
tricuspid patients, leading to no significant difference between
the two groups. Support for this also comes from marked
improvement in aortic stiffness in patients with severe AS
1 year after aortic valve replacement [28].
Pathophysiology of aortic dilatation
The exact mechanism leading to dilatation of the aorta in
bicuspid patients is unclear. Histopathological studies have
demonstrated changes in the AA walls of bicuspid patients
including cystic medial necrosis [6]. High rates of apoptosis
in the aortic media of bicuspid patients both with and without
Table 2 Aortic area, distensibility, and pulse wave velocity in bicuspid and tricuspid groups
Bicuspid (n = 63) Tricuspid (n = 106) p value
(bi vs tri)
p value after correcting
for age (bi vs tri)
Controls (n = 23)
AAmax (cm2) 12.97 [11.10, 15.59] 10.06 [8.57, 12.04] < 0.001* < 0.001* 9.46 [7.85, 10.48] †
DAmax (cm2) 5.84 [4.76, 6.59] 6.07 [5.17, 7.32] 0.020* 0.902 5.18 [4.68, 5.92] †
AAmin (cm2) 11.57 [10.08, 14.11] 9.00 [7.56, 10.66] < 0.001* < 0.001* 8.98 [7.24, 9.49] †
DA min (cm2) 5.27 [4.07, 5.74] 5.52 [4.67, 6.66] 0.013* 0.980 4.54 [4.27, 5.53] †
AA distensibility (10-3 mmHg-1) 1.64 [1.17, 3.02] 1.58 [1.20, 2.07] 0.396 0.099 1.23 [0.73, 1.73] †
DA distensibility (10-3 mmHg-1) 2.45 [1.43, 2.89] 1.55 [1.10, 2.18] < 0.001* 0.498 1.40 [1.05, 1.95]
PWV (m/s) 7.44 [4.88, 10.51] 7.88 [6.32, 9.92] 0.150 0.235 8.20 [6.83, 8.97]
Data presented as median [25th, 75th percentile]. Column-4 shows p values using the Mann-Whitney U test; column-5 shows p values after correcting
for age, using one-way ANCOVA test of log-transformed data *p < 0.05
AAmax/min maximum/minimum ascending aortic area, DAmax/min maximum/ minimum descending aortic area, PWV pulse wave velocity
† p < 0.05 for comparison of controls with AS patients after correcting for age using one-way ANCOVA test of log-transformed data
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Fig. 3 Scatter plots showing the relationship of age with distensibility (a, b) and pulse wave velocity (c) and of distensibility with cross-sectional area in
the ascending aorta (d). Units—distensibility, 10−3 mmHg−1; PWV, m/s; AA area, mm2; age years
Table 3 Aortic area, distensibility, and pulse wave velocity in tricuspid, bicuspid type-I, and type-II sub-group comparison using age as a covariate
Tricuspid
(n = 106)
Bicuspid type-I
(n = 41)
Bicuspid type-II
(n = 22)
p value (AS
sub-groups only)
Controls
(n = 23)
p value (AS
sub-groups
and controls)
AA max (cm2) 10.06 [8.57,12.04]† ‡ 12.82 [10.62,14.95] 13.28 [11.97, 16.20] < 0.001* 9.46 [7.85, 10.48]† ‡ < 0.001*
DA max (cm2) 6.07 [5.17, 7.32] 5.89 [4.87, 6.60] 5.32 [4.05, 6.54] 0.953 5.18 [4.68, 5.92] 0.102
AA distensibility
(10−3 mmHg−1)
1.58 [1.20, 2.07]† 1.47 [1.02, 1.79]‡ 2.60 [1.27, 3.51] 0.010* 1.23 [0.73, 1.73]° ‡ < 0.001*
DA distensibility
(10−3 mmHg−1)
1.55 [1.10, 2.18] 2.26 [1.40, 2.89] 2.51 [1.63, 2.84] 0.729 1.40 [1.05, 1.95] 0.638
PWV (m/s) 7.88 [6.32, 9.92]† 8.94 [6.34, 11.96]‡ 4.99 [4.61, 7.06] 0.001* 8.20 [6.83, 8.97] 0.002*
Abbreviations same as for Table 2. Data presented as median [25th, 75th centile]. Age-corrected p values obtained using ANCOVA test of log-
transformed values with age as a covariate
*p < 0.05
† Significant difference compared to bicuspid type-I
‡ Significant difference compared to bicuspid type-II
°Significant difference compared to tricuspid on post-HOC analysis using Bonferroni test
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dilatation have been shown, suggesting that apoptosis is a key
mechanism for smoothmuscle cell loss in the ascending aortas
of bicuspid patients, and supporting the hypothesis of a devel-
opmental fault involving the valve and aortic wall [5].
However, a similarly high rate of apoptosis was also found
in tricuspid patients with aortic dilatation, suggesting a role of
extrinsic forces on the aortic wall, rather than an intrinsic
developmental abnormality alone. Cystic medial necrosis
can be found in hereditary connective tissue disorders such
as Marfan syndrome, which has consistently been associated
with increased aortic stiffness [29, 30], but a similar histolog-
ical picture can also be caused by infection, atherosclerosis or
severe shear stress [5].
We have shown a dissociation between aortic dilatation and
stiffness in BAV disease, with type-II group having lower
stiffness parameters, despite a trend towards a higher AA area,
further confounding the theory of intrinsic aortic wall stiffness
alone leading to aortic dilatation in bicuspid patients. In fact,
there was no correlation between AA distensibility and AA
dimensions (Fig. 3d). This may suggest a more central role of
asymmetrical flow patterns and worse turbulence [31] that has
been demonstrated in BAV compared to TAV [7, 8], which
also correlated with the degree of proximal aortic dilatation
[32]. Recently, time-resolved three-dimensional phase-
contrast MRI, also called 4D flow, has demonstrated right-
handed helical flow and right-anterior flow jets in type-I
BAV, and left-handed helical flow with left-posterior flow jets
in type-II BAV [31].
In abdominal aortic aneurysms (AAA), Wilson et al dem-
onstrated increasing aortic distensibility to be an independent
predictor of rupture and suggested that this may be due to
failure of aortic wall remodelling, which leads to further dila-
tation and risk of rupture [33]. This is supported by another
study showing no correlation between AAA distensibility and
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size [34]. The authors speculated that the wall of the rapidly
expanding AAA may lose its integrity leading to a paradoxi-
cally increased distensibility, which may also in part explain
our findings in type-II BAV patients.
There appear to be two key players: age being a key deter-
minant of aortic stiffness, with valve haemodynamics (morphol-
ogy ± presence of stenosis/regurgitation) being central to aortic
dilatation. In a previously published set of young controls using
the samemethodology, themedianAAdistensibility was 6.36 ×
10−3 mmHg−1 and PWV was 3.97 m/s [35], demonstrating
much lower stiffness than this group of patients or older controls.
Cecconi found no difference in aortic size between young BAV
type-I, and type-II patients with no stenosis/regurgitation [24],
whereas type-II BAV patients with mixed valve disease (dys-
functional valves) had larger aortas but similar distensibility to
type-I patients in Schaefer’s study [36]. Finally, our older cohort
of BAV and TAV with AS demonstrated no significant differ-
ence in aortic stiffness, despite larger aortas in BAV.
Limitations
The cross-sectional nature of the observations precludes any
inference about the causality of the associated observations,
and the results should be considered hypothesis generating.
The bicuspid group were younger, and age is an important
determinant of aortic stiffness. However, BAV presents at an
earlier age, and we corrected for age in our analysis to try and
overcome this limitation. We cannot exclude the possibility
that the omission from the study of younger patients with BAV
and complications, such as aortic dissection, potentially biased
the results by excluding those at highest risk. Sub-group anal-
ysis of BAV was limited with relatively small sample size.
Four-dimensional flow sequences were not acquired and
therefore we could not correlate flow pattern with measures
of stiffness. We also did not correct for longitudinal motion of
the aortic root during systole, though the measurement was
made more distally in the ascending aorta.
Conclusions
In patients with significant AS, BAV patients do not have
increased aortic stiffness compared to those with TAV de-
spite increased ascending aortic dimensions. The AA of
patients with type-II BAV has the highest distensibility
and lowest PWV despite the greatest dimensions. These
results demonstrate a dissociation between aortic dilatation
and stiffness and suggest that altered flow patterns may
play a role which requires further assessment with longitu-
dinal studies.
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